These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 21654615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S.
    Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW, Chu EY, Xu L.
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
    Chaki O.
    Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
    Silverman SL, Christiansen C, Genant HK, Vukicevic S, Zanchetta JR, de Villiers TJ, Constantine GD, Chines AA.
    J Bone Miner Res; 2008 Dec; 23(12):1923-34. PubMed ID: 18665787
    [Abstract] [Full Text] [Related]

  • 9. [Bazedoxifene as a new-generation SERM].
    Ohta H.
    Clin Calcium; 2011 Jan; 21(1):34-42. PubMed ID: 21187592
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV, Thomas S.
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [Abstract] [Full Text] [Related]

  • 12. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
    Sambrook P.
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
    de Villiers TJ.
    Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
    [Abstract] [Full Text] [Related]

  • 15. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
    Hart W, Netelenbos JC.
    Ned Tijdschr Geneeskd; 1999 Aug 28; 143(35):1771-6. PubMed ID: 10494328
    [Abstract] [Full Text] [Related]

  • 16. Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial.
    Bachmann G, Crosby U, Feldman RA, Ronkin S, Constantine GD.
    Menopause; 2011 May 28; 18(5):508-14. PubMed ID: 21289525
    [Abstract] [Full Text] [Related]

  • 17. [Selective estrogen receptor modulators (SERMs)].
    Chaki O.
    Nihon Rinsho; 2015 Oct 28; 73(10):1673-81. PubMed ID: 26529929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.